FibroGen (FGEN) Stock Price
$11.18 0.8%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
1 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on FibroGen, AI stock picks, stock alerts and much more.
FGEN AI Stock Analysis
AI stock analysis for FGEN is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like FibroGen (FGEN) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
FibroGen (FGEN) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of FibroGen (FGEN), currently trading at $11.18, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About FGEN
-
FibroGen, Inc.
-
Symbol
FGEN
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
45.2M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.08 2.5% |
8 |
 |
Inovio Pharmaceuticals INO |
$1.96 2.6% |
3 |
 |
Moderna MRNA |
$27.12 3.4% |
3 |
 |
Anavex Life Sciences AVXL |
$9.53 0.2% |
5 |
 |
BridgeBio Pharma BBIO |
$49.08 2.3% |
6 |
News
FGEN Alternative Data
Web Traffic
FibroGen receives an estimated 6011 monthly visitors to fibrogen.com.
-
Web Traffic
6011
-
Change from Previous Month
44.9%
-
3 Month Change
52.1%
-
YoY Change
52.1%
Twitter Followers
FibroGen has 986 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.4% over the last month.
-
Twitter Followers
986
-
Daily Change
0%
-
1 Month Change
0.4%
-
3 Month Change
0.4%
-
YoY Change
0.4%
LinkedIn Followers
17,060 are following FibroGen on LinkedIn, up by 0.3% over the last month.
-
LinkedIn Followers
17060
-
Daily Change
0%
-
1 Month Change
0.3%
-
3 Month Change
1.2%
Job Postings
FibroGen currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, FibroGen has 300 employees, down by -2% over the last month.
-
LinkedIn Employees
300
-
Daily Change
0%
-
1 Month Change
2%
-
3 Month Change
5.4%
-
YoY Change
5.4%
Business Outlook
According to employee reviews, the business outlook among employees at FibroGen is 41 out of 100 (neutral).
-
Business Outlook
41
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
Reddit Mentions
FibroGen has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
News Mentions
FibroGen was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
FGEN Financials
FGEN Key Metrics
-
Total Revenue
-$123.3M
-
Net Income
$18M
-
Earnings per Share
$0.18
-
Free cash flow
-$30.6M
-
EBITDA
-$91.1M
-
EBITDA Ratio
0.739112
-
Total Assets
$214.5M
FGEN 2-year Revenue & Income
FGEN 2-year Free Cash Flow
FGEN Technicals
FGEN SMA
FGEN RSI
FAQ
What's the current price of FibroGen (FGEN) Stock?
The price of an FibroGen (FGEN) share is $11.18.
What's the market cap of FibroGen?
The current market cap of FibroGen is 45.2M.
Should I buy or sell FGEN?
FibroGen shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, FibroGen is better viewed as a hold or accumulate position while waiting for further developments.
Is FibroGen a good investment?
The current analysis of FibroGen's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in FibroGen's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy FibroGen (FGEN) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for FibroGen stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to FibroGen (FGEN) that investors often compare it to?
FibroGen (FGEN) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for FibroGen's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast FibroGen's stock price to be around $10.65 in 2026. Starting from the current price of $11.18, this represents a 4.7% change in price, indicating a bearish outlook for the stock.
How to buy FibroGen (FGEN) Stock?
FibroGen stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy FibroGen shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.